Research progress of exosomes in drug resistance of breast cancer
Open Access
- 4 January 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 11, 1214648
Abstract
Since breast cancer is a heterogeneous disease, there are currently a variety of treatment methods available, including chemotherapy, endocrine therapy, molecular targeted therapy, immunotherapy, radiation therapy, etc. Breast cancer recurrence and metastasis, despite many treatment modalities, constitute a considerable threat to patients’ survival time and pose a clinical challenge that is difficult to tackle precisely. Exosomes have a very special and crucial role in the treatment of drug resistance in breast cancer as a carrier of intercellular communication in the tumor microenvironment. Exosomes and breast cancer treatment resistance have been linked in a growing number of clinical investigations in recent years. This paper covers the status of research on exosomes in the treatment of breast cancer drug resistance and offers theoretical guidance for investigating new strategies to treat breast cancer drug resistance.Keywords
This publication has 137 references indexed in Scilit:
- PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer CellsPLOS ONE, 2014
- Cancer drug resistance: an evolving paradigmNature Reviews Cancer, 2013
- Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cellsProceedings of the National Academy of Sciences, 2012
- The relationships between snail1 and estrogen receptor signaling in breast cancer cellsJournal of Cellular Biochemistry, 2012
- Mechanisms of Endocrine Resistance in Breast CancerAnnual Review of Medicine, 2011
- Survivin is released from cancer cells via exosomesApoptosis, 2010
- HER2 as a target for breast cancer therapyExpert Opinion on Biological Therapy, 2010
- Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomesExperimental Cell Research, 2009
- Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cellsLeukemia, 2009
- Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cellsProceedings of the National Academy of Sciences, 2005